| 3.785 -0.015 (-0.39%) | 09-13 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.18 | 1-year : | 6.05 |
| Resists | First : | 4.44 | Second : | 5.18 |
| Pivot price | 3.68 |
|||
| Supports | First : | 3.4  |
Second : | 2.76 |
| MAs | MA(5) : | 3.88 |
MA(20) : | 3.71 |
| MA(100) : | 4.53 |
MA(250) : | 6.81 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 70.6 |
D(3) : | 71.9 |
| RSI | RSI(14): 48.7 |
|||
| 52-week | High : | 12.53 | Low : | 2.7 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ XYLO ] has closed below upper band by 37.1%. Bollinger Bands are 54% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 4 - 4.02 | 4.02 - 4.04 |
| Low: | 3.6 - 3.62 | 3.62 - 3.64 |
| Close: | 3.74 - 3.78 | 3.78 - 3.82 |
Thu, 15 Aug 2024
Xylo’s ParaZero Boosts Medical Delivery with Drone Safety Tech - TipRanks
Thu, 15 Aug 2024
Xylo Technologies: ParaZero Received Order from a Leading Tier-One Defense Company for 50 Drone Safety Systems - Yahoo Finance
Wed, 14 Aug 2024
Xylo Technologies: Revoltz to Launch an Innovative Three-Wheel Electric Cargo Bike for European and UK Markets - StockTitan
Tue, 30 Jul 2024
Xylo Technologies Announces ADR Program Reverse Split - TipRanks
Tue, 30 Jul 2024
Xylo Technologies Announces Plan to Implement ADS Ratio Change - StockTitan
Tue, 30 Jul 2024
Xylo Technologies Announces Plan to Implement ADS Ratio Change - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Specialties
|
|
| Shares Out | 1 (M) |
| Shares Float | 28 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0.4 (%) |
| Shares Short | 3 (K) |
| Shares Short P.Month | 3 (K) |
| EPS | -25.21 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 33.68 |
| Profit Margin | -17.5 % |
| Operating Margin | -16.3 % |
| Return on Assets (ttm) | -8.4 % |
| Return on Equity (ttm) | -49.9 % |
| Qtrly Rev. Growth | -32.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 129.09 |
| EBITDA (p.s.) | -9.63 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -6 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -0.16 |
| PEG Ratio | 0 |
| Price to Book value | 0.11 |
| Price to Sales | 0.02 |
| Price to Cash Flow | -0.44 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|